Immune Pharmaceuticals Announces New Data with Topical Cyclosporine Nano-Capsules in Dermatology - Stock Watch Index

Immune Pharmaceuticals Announces New Data with Topical Cyclosporine Nano-Capsules in Dermatology

February 1, 2016

Immune Acquires Worldwide Rights and Accelerates Development for the Treatment of Psoriasis and Atopic Dermatitis NEW YORK, Jan. 4, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company, announced today that following the review of new efficacy data, it has entered into an exclusive worldwide licensing and development agreement with BioNanoSim Ltd…

Search

RECENT PRESS RELEASES

Man Who Accidentally Threw Away Bitcoin Worth $800 Million Looks To Trump For Help: ‘I Am Appealing To Him’

SWI Editorial Staff2025-01-16T05:09:41-08:00January 16, 2025|

Bitcoin Breakout Alert: Research Company Head Shares Key Timeline

SWI Editorial Staff2025-01-18T19:34:56-08:00January 16, 2025|

XRP Price Gains 10%, Stealing The Spotlight from Bitcoin

SWI Editorial Staff2025-01-16T05:09:38-08:00January 16, 2025|

Pension funds dabble in crypto after massive bitcoin rally

SWI Editorial Staff2025-01-18T19:45:31-08:00January 16, 2025|

Is Bitcoin’s Upward Cycle Back? Key Insights Into The Latest Recovery

SWI Editorial Staff2025-01-16T05:09:33-08:00January 16, 2025|

Bitcoin Could Top $300,000 This Year, New HashKey Survey Claims

SWI Editorial Staff2025-01-16T05:09:30-08:00January 16, 2025|

Related Post